Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.solara.co.in | |
Market Cap | 1,525.88 Cr. | |
Enterprise Value(EV) | 2,529.32 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -6.68 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 33.61 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 416.12 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.02 | Calculated using Price: 423.90 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 3.60 Cr. | 35,996,267 Shares |
FaceValue | 10 | |
Company Profile | ||
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. |
1 Day |
|
-4.38% |
1 Week |
|
+0.48% |
1 Month |
|
-2.80% |
3 Month |
|
+1.10% |
6 Month |
|
+18.72% |
1 Year |
|
-56.17% |
2 Year |
|
-67.78% |
5 Year |
|
|
10 Year |
|
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 0.04 | 7.36 | 12.48 | 17.23 | -3.75 | |
Return on Capital Employed (%) | 1.82 | 9.70 | 11.73 | 15.34 | -0.67 | |
Return on Assets (%) | 0.02 | 3.14 | 5.57 | 9.34 | -2.13 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 764 | 956 | 1,086 | 1,589 | 1,525 | 1,498 | |
Non Curr. Liab. | 315 | 344 | 333 | 206 | 299 | 212 | |
Curr. Liab. | 738 | 656 | 730 | 789 | 1,071 | 1,073 | |
Minority Int. | 4 | 4 | 4 | 4 | 2 | 2 | |
Equity & Liab. | 1,821 | 1,960 | 2,153 | 2,588 | 2,897 | 2,786 | |
Non Curr. Assets | 1,214 | 1,312 | 1,481 | 1,530 | 1,658 | 1,650 | |
Curr. Assets | 608 | 648 | 672 | 1,058 | 1,239 | 1,136 | |
Misc. Exp. not W/O | |||||||
Total Assets | 1,821 | 1,960 | 2,153 | 2,588 | 2,897 | 2,786 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 560 | 1,409 | 1,322 | 1,617 | 1,268 | 1,424 | |
Other Income | 2 | 12 | 28 | 29 | 20 | 24 | |
Total Income | 563 | 1,421 | 1,349 | 1,646 | 1,288 | 1,448 | |
Total Expenditure | -501 | -1,197 | -1,062 | -1,231 | -1,188 | -1,325 | |
PBIDT | 62 | 224 | 287 | 415 | 100 | 123 | |
Interest | -25 | -82 | -78 | -84 | -75 | -90 | |
Depreciation | -37 | -84 | -94 | -109 | -112 | -113 | |
Taxation | 0 | 2 | 0 | 0 | 33 | 57 | |
Exceptional Items | -3 | -1 | |||||
PAT | 0 | 59 | 115 | 221 | -58 | -24 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | |
Share Associate | |||||||
Other Related Items | |||||||
Consolidated Net Profit | 0 | 60 | 115 | 221 | -58 | -24 | |
Adjusted EPS | 0 | 23 | 43 | 62 | -16 | -7 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 49 | 166 | 242 | 155 | -242 | |
Cash Fr. Inv. | -85 | -116 | -359 | -106 | -243 | |
Cash Fr. Finan. | 68 | -23 | 97 | 92 | 334 | |
Net Change | 31 | 27 | -20 | 142 | -151 | |
Cash & Cash Eqvt | 46 | 76 | 56 | 198 | 46 |
Wed, 25 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Wed, 25 Jan 2023
Appointment
|
|
Wed, 25 Jan 2023
ESOP/ESOS/ESPS
|
Wed, 25 Jan 2023 |
|
|
|
|
|